{"id":"a94f8a66-a01c-4ad8-a7e0-ffc506622509","modelId":"cd51c658-641a-4d09-b0ac-57aaf6874f42","versionId":null,"locationId":"0b7f16f7-9f8c-4105-b458-f98c50d360ef","operatorId":null,"ownerId":null,"slug":"liberty-endovascular-atlanta-georgia-usa","status":"operational","firstSeen":"2026-03-26T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":null,"shiftStructure":null,"hoursPerDay":null,"siteType":null,"operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":null,"deploymentScale":null,"siteEnvironment":null,"operatorType":null,"sourceQualityTier":null,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://ir.microbotmedical.com/news-releases/news-release-details/emory-healthcare-successfully-completes-robotic-peripheral","label":"Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures Using LIBERTY System","title":"Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures Using LIBERTY System","mediaType":"article","sourceName":"Microbot Medical IR","publishedAt":"2026-03-26"}],"notes":"Emory Healthcare — first hospital in the world to adopt the LIBERTY system. Performed world's first robotic prostate artery embolization (PAE) and Y-90 radioembolization mapping for liver cancer.","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":null,"scaleTier":null,"contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-11T05:03:54.375Z","updatedAt":"2026-08-14T13:33:23.512Z","model":{"id":"cd51c658-641a-4d09-b0ac-57aaf6874f42","companyId":"02ead9de-6bce-472d-9e76-d9c954d8d603","modelName":"LIBERTY Endovascular Robotic System","slug":"liberty-endovascular","description":"Microbot Medical is a Hingham, MA-based commercial-stage medical device company (Nasdaq: MBOT) that developed the [LIBERTY Endovascular Robotic System](/models/liberty-endovascular-robotic-system), the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The LIBERTY system received FDA 510(k) clearance in 2025.","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://ir.microbotmedical.com/news-events/press-release","title":"Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System","sourceName":"GlobeNewswire"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"FDA cleared","value":"LIBERTY Endovascular Robotic System; Nasdaq=MBOT"},{"label":"Stock","value":"Nasdaq: MBOT"},{"label":"Product","value":"LIBERTY Endovascular Robotic System"},{"label":"FDA clearance","value":"510(k) (2025)"},{"label":"Key feature","value":"Single-use, remotely operated"},{"label":"Ticker","value":"MBOT (Nasdaq)"},{"label":"Category","value":"Endovascular surgical robotics"}],"createdAt":"2026-07-02T21:26:26.322Z","updatedAt":"2026-07-12T04:24:54.291Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"02ead9de-6bce-472d-9e76-d9c954d8d603","name":"Microbot Medical","slug":"microbot-medical","description":"Microbot Medical Inc. (Nasdaq: MBOT) is a commercial-stage medical device company developing the [LIBERTY Endovascular Robotic System](/models/liberty-endovascular-robotic-system), the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The company received FDA 510(k) clearance in September 2025 and commenced limited market release in November 2025, expanding to a full market release in Q2 2026. Headquartered in Hingham, Massachusetts with R&D operations in Yokneam, Israel.","status":null,"founded":2011,"hq":"Hingham, MA, USA","hqLat":42.2417669,"hqLng":-70.8897676,"hqGeocodedAt":"2026-08-05T00:51:16.415Z","hqAddress":null,"hqPrecision":null,"website":"microbotmedical.com","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://ir.microbotmedical.com/news-events/press-release","title":"Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System","sourceName":"GlobeNewswire"}],"keyFacts":[{"label":"FDA cleared","value":"LIBERTY Endovascular Robotic System; Nasdaq=MBOT"},{"label":"Stock","value":"Nasdaq: MBOT"},{"label":"Product","value":"LIBERTY Endovascular Robotic System"},{"label":"FDA clearance","value":"510(k) (2025)"},{"label":"Key feature","value":"Single-use, remotely operated"},{"label":"Ticker","value":"MBOT (Nasdaq)"},{"label":"Category","value":"Endovascular surgical robotics"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"MBOT","stockExchange":"NASDAQ","secCik":"0000883975","revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-02T21:26:26.164Z","updatedAt":"2026-08-11T05:02:09.994Z"}},"version":null,"location":{"id":"0b7f16f7-9f8c-4105-b458-f98c50d360ef","name":"Atlanta, Georgia, USA","slug":"atlanta-georgia-usa","kind":"city","parentLocationId":null,"region":null,"lat":33.7544657,"lng":-84.3898151,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":"Coordinates auto-geocoded on create via OpenStreetMap Nominatim (unverified; confirm before relying on map placement).","createdAt":"2026-08-08T19:00:23.021Z","updatedAt":"2026-08-09T04:26:19.821Z"},"operator":null,"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/liberty-endovascular-atlanta-georgia-usa","url":"https://registry.deploy.report/deployments/liberty-endovascular-atlanta-georgia-usa","name":"LIBERTY Endovascular Robotic System at Atlanta, Georgia, USA","identifier":"a94f8a66-a01c-4ad8-a7e0-ffc506622509","startDate":"2026-03-26T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/atlanta-georgia-usa","name":"Atlanta, Georgia, USA"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/microbot-medical","name":"Microbot Medical"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/liberty-endovascular","name":"LIBERTY Endovascular Robotic System"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":["primary-company-ir"]}}}